Philips IQon Spectral CT Recall

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Philips Medical Systems is recalling 42 IQon Spectral CT units nationwide due to potential scan triggering issues that may lead to inadequate imaging and additional radiation exposure.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on August 13, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.

What Happened

The clinical CT scan may not automatically trigger after the Bolus Tracking scan and may need to be triggered manually. Additional Bolus Tracking shots may occur. This may result in the clinical acquisition being inadequate for diagnosis, causing a potential for patient rescan and receiving additional radiation.

Which Products Are Affected

IQon Spectral CT and IQon Spectral CT Upgrades. 42 units affected. Codes: FCO72800812; FCO72800814 728331 728332, DI (01)00884838059542. Distributed via US Nationwide Distribution including Puerto Rico. Recall number Z-2651-2026. Class II recall initiated June 11, 2026.

What You Should Do

Refer to the recall notice for further instructions from the recalling firm.

Why This Matters

The issue may result in inadequate diagnostic imaging and additional patient radiation exposure.

Source

FDA recall Z-2651-2026, event ID 99352. Recalling firm: PHILIPS MEDICAL SYSTEMS, Cambridge, MA.

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Philips Medical Systems is recalling 42 IQon Spectral CT units nationwide due to potential scan triggering issues that may lead to inadequate imaging and additional radiation exposure.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.